8-K - Barinthus Biotherapeutics plc | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Barinthus Biotherapeutics plc announced that Gemma Jones will step down as principal accounting officer effective April 30, 2026, following her notification on March 27, 2026.

Key Takeaways

1Gemma Jones notified the company on March 27, 2026, of her intention to step down as principal accounting officer.

2Her departure will become effective on April 30, 2026.

3Jones provides services to the company as an employee of CFGI while serving as principal accounting officer.

4The filing contains forward-looking statements regarding the intended departure and its timing, subject to risks and uncertainties.

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** As previo

Management Change

Executive & Director Changes

Gemma Jones

principal accounting officer

step down

Effective: 2026-04-30

notified the Company

Exhibits (1)

8-K

FORM 8-K